ArticleFrontiers in oncology2026
Thyroid cancer among children and adolescents aged 5-19 years from 1990 to 2021: a global, regional, and national perspective.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Thyroid cancer in children and adolescents (caTC) is characterized by a higher degree of malignancy, as well as an increased risk of distant metastasis and recurrence compared to thyroid cancer in adults. At present, new analyses of the global burden of caTC are limited and outdated. To conduct a comprehensive and systematic investigation into the burden and trends of caTC across the global population. Methods: Data were gathered from the Global Burden of Disease (GBD) study in 2021. A detailed analysis was performed using age-standardized incidence rate (ASIR), age-standardized prevalence rate (ASPR), Age-Standardized Disability-Adjusted Life Years (ASDR), and average annual percent change (AAPC). Joinpoint regression, cross-country inequality, decomposition, and frontier analyses were conducted. Results: In 2021, we discovered a total of 4, 951.78 new caTC cases globally, along with 30, 499.94 DALYs. The age-standardized rates (ASRs) were 0.24 per 100, 000 population for incidence and 1.52 per 100, 000 for DALYs. In trend analysis, the global incidence (AAPC, 1.00) and prevalence (AAPC, 1.05) exhibited an increasing pattern, while the DALYs (AAPC, -0.37) declined. The ASIR of caTC in Africa, America, and Asia demonstrated a continuous upward trend, whereas Europe witnessed a decline. Consistently, the ASIR, ASPR, and ASDR of caTC were all higher among women compared to men. Notably, countries with low SDI bore a higher disease burden. Population growth and epidemiological changes were the primary drivers of this increased disease burden. Despite different levels of development, many countries still had considerable potential to reduce these disease burdens. Conclusions: CaTC persists as a significant public health concern globally. Its burden varies considerably in terms of global distribution and magnitude, thereby emphasizing the necessity for the formulation of targeted regional and population-based policies aimed at primary prevention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.